Ligand Pharmaceuticals Inc (NASDAQ:LGND)
| 139.27 Delayed Data As of Sep 24 |  -3.66 / -2.56%Today’s Change | 78.26 Today|||52-Week Range 219.75 | +40.04% Year-to-Date |
Latest LGND News | Press Releases
No recent news for Ligand Pharmaceuticals Inc.
Today’s Trading
| Previous close | 142.93 |
| Today’s open | 142.77 |
| Day’s range | 139.22 - 143.49 |
| Volume | 3,346 |
| Average volume (3 months) | 209,414 |
| Market cap | $2.4B |
Data as of 4:14pm ET, 09/24/2021
Growth & Valuation
| Earnings growth (last year) | -100.56% |
| Earnings growth (this year) | +29.89% |
| Earnings growth (next 5 years) | +22.50% |
| Revenue growth (last year) | +54.98% |
| P/E ratio | 49.9 |
| Price/Sales | 8.63 |
| Price/Book | 3.27 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| VCELVericel Corp | -0.86 | -1.72% |
| CORTCorcept Therapeutics... | -0.18 | -0.88% |
| ---- | ||
| ---- |
Data as of 4:14pm ET, 09/24/2021
Financials
| Next reporting date | November 11, 2021 |
| EPS forecast (this quarter) | $1.07 |
| Annual revenue (last year) | $186.4M |
| Annual profit (last year) | -$3.0M |
| Net profit margin | -1.60% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters San Diego, California |
Forecasts
